pISSN 1226-4512 eISSN 2093-3827

Article

home Article View

Review Article

Korean J Physiol Pharmacol 2019; 23(6): 427-448

Published online November 1, 2019 https://doi.org/10.4196/kjpp.2019.23.6.427

Copyright © The Korean Journal of Physiology & Pharmacology.

Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists

Jong Yung Park#, Suji Chae#, Chang Seop Kim, Yoon Jae Kim, Hyun Joo Yi, Eunjoo Han, Youngshin Joo, Surim Hong, Jae Won Yun, Hyojung Kim, and Kyung Ho Shin*

Department of Pharmacology, Korea University College of Medicine, Seoul 02841, Korea

Correspondence to:Kyung Ho Shin
E-mail: kyungho@korea.ac.kr

#These authors contributed equally to this work.

Received: June 12, 2019; Revised: August 11, 2019; Accepted: August 26, 2019

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Nociceptin/orphanin FQ (N/OFQ) and its receptor, nociceptin opioid peptide (NOP) receptor, are localized in brain areas implicated in depression including the amygdala, bed nucleus of the stria terminalis, habenula, and monoaminergic nuclei in the brain stem. N/OFQ inhibits neuronal excitability of monoaminergic neurons and monoamine release from their terminals by activation of G protein-coupled inwardly rectifying K+ channels and inhibition of voltage sensitive calcium channels, respectively. Therefore, NOP receptor antagonists have been proposed as a potential antidepressant. Indeed, mounting evidence shows that NOP receptor antagonists have antidepressant-like effects in various preclinical animal models of depression, and recent clinical studies again confirmed the idea that blockade of NOP receptor signaling could provide a novel strategy for the treatment of depression. In this review, we describe the pharmacological effects of N/OFQ in relation to depression and explore the possible mechanism of NOP receptor antagonists as potential antidepressants.

Keywords: Antidepressive agents, Depression, Neuropeptide, Receptors, drug